Claudio Laudani on PCSK9 Association with Increased Platelet Reactivity: A Pooled Analysis
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:
”Circulating PCSK9 has been associated with increased platelet reactivity and adverse outcomes in patients with atherosclerotic cardiovascular disease.
However, the relative effects of additional PCSK9 inhibitions on platelet reactivity in patients on DAPT and chronic statin therapy has not been evaluated.
To answer this gap in knowledge, we performed a collaborative individual patient data meta-analysis of randomized controlled trials finding that, although PCSK9 inhibitors significantly reduced circulating lipoproteins, such reduction did not translate into any significant change in platelet reactivity at 4 weeks.
These results suggest that the effects of PCSK9 inhibitors are mostly related to plaque stabilization rather than an off-target effect on platelets.”
Read the full article here.
Article: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies
Authors: Luis Ortega-Paz, Yasushi Ueki, Claudio Laudani, Sylvain Losdat, Francesco Franchi, Ryota Kakizaki, Fabiana Rollini, Jonas Häner, Lorenz Räber, Dominick J. Angiolillo
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 10:24Vishnu Priya Pulipati: The Endocrinologist’s Role in Lp(a) and Cardiovascular Risk Reduction
-
Oct 5, 2026, 09:59William McKeown – A Busy Week with the European Haemophilia Consortium
-
Oct 5, 2026, 09:46Megan Buchholz – Celebrating Apheresis Awareness Day 2026 at St. Michael’s Hospital
-
Oct 5, 2026, 09:34ITP Myth vs. Fact – A Common Misconception – ITP Support Association
-
Oct 5, 2026, 09:20Jan Sloves: Medial Thigh Venous Perforators – Why Diameter Isn’t the Whole Story
-
Oct 5, 2026, 09:16Emmanuele Kouvousis: ASH Sets New Standards for Diagnosing Iron Deficiency
-
Oct 5, 2026, 09:12Arun V J: Fresh Whole Blood vs Evidence-Based Transfusion
-
Oct 5, 2026, 09:06Edward Lee Carter: NOTION-4 – HALT and Clinical Outcomes
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding